This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.

Search form

The White House
For Immediate Release

Statement by Director Kerlikowske on Congress' Passage of the Food and Drug Administration Safety and Innovation Act (S.3187)

The Office of National Drug Control Policy commends Congress for passing the Food and Drug Administration Safety and Innovation Act, S. 3187, which requires 26 synthetic chemicals, including those commonly found in products marketed as “K2” and “Spice,” to be considered Schedule I substances.  Schedule I substances are those with a high potential for abuse; have no medical use in treatment in the United States; and lack an accepted safety for use of the drug.

“I applaud Congress for coming together on this issue that is affecting so many of our young people. Research shows that parents are the most powerful force in the lives of young people,” said Director Kerlikowske.  “Synthetic drugs like ‘bath salts,’ Spice, and K2 are a serious threat to health and safety.  I urge families to take time today to learn what these drugs are and discuss the harms that all drugs pose to young people in America.”

As part of ongoing efforts to coordinate the Federal response to the drug threat, in February, the ONDCP joined The Partnership at to introduce a kit for parents and adult influencers housing the tools they need to talk with their teens about this emerging threat and recognize the warning signs of use. The information kit includes a slidecast about synthetic drugs, a corresponding podcast and video, and a printable guide so parents can present details on what to look for, what the street names are and what the effects of these substances are to others in their community.  It is available at The Partnership at website and is part of a "Parents360" community education program funded by the U.S. Department of Justice, Bureau of Justice Assistance.